S
MRVI icon

SignatureFD’s Maravai LifeSciences MRVI Stock Holding History

SignatureFD’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76K Sell
12,172
-2,126
-15% -$9.18K ﹤0.01% 1612
2026
Q1 		$40.5K Hold
14,298
– – ﹤0.01% 1850
2025
Q4 		$46.5K Buy
14,298
+475
+3% +$1.6K ﹤0.01% 1695
2025
Q3 		$39.7K Buy
13,823
+3,841
+38% +$9.81K ﹤0.01% 1762
2025
Q2 		$24.1K Buy
9,982
+4,723
+90% +$9.93K ﹤0.01% 1969
2025
Q1 		$11.6K Buy
5,259
+2,464
+88% +$9.74K ﹤0.01% 2296
2024
Q4 		$15.2K Sell
2,795
-3,625
-56% -$23.3K ﹤0.01% 2200
2024
Q3 		$53.4K Sell
6,420
-356
-5% -$3.08K ﹤0.01% 1541
2024
Q2 		$48.5K Buy
6,776
+674
+11% +$5.82K ﹤0.01% 1526
2024
Q1 		$52.9K Buy
6,102
+1,470
+32% +$9.95K ﹤0.01% 1522
2023
Q4 		$30.3K Buy
4,632
+1,268
+38% +$8.19K ﹤0.01% 1716
2023
Q3 		$33.6K Buy
3,364
+1,681
+100% +$18.5K ﹤0.01% 1599
2023
Q2 		$20.9K Sell
1,683
-3,114
-65% -$42K ﹤0.01% 1861
2023
Q1 		$67.2K Buy
4,797
+2,835
+144% +$40.7K ﹤0.01% 1238
2022
Q4 		$28.1K Buy
1,962
+760
+63% +$12K ﹤0.01% 1640
2022
Q3 		$31K Buy
1,202
+802
+201% +$20.1K ﹤0.01% 1532
2022
Q2 		$11K Hold
400
– – ﹤0.01% 2073
2022
Q1 		$14K Hold
400
– – ﹤0.01% 2006
2021
Q4 		$17K Buy
400
+200
+100% +$8.1K ﹤0.01% 1858
2021
Q3 		$10K Buy
+200
New +$9.76K ﹤0.01% 2072

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

SignatureFD's MRVI Position: Q2 2026 in Review

SignatureFD reduced its Maravai LifeSciences (MRVI) stake by 15% in Q2 2026, selling an estimated $9.18K and leaving 12,172 shares worth $76K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

SignatureFD first reported a position in MRVI in Q3 2021 and has held it in 20 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • SignatureFD held 12,172 shares of Maravai LifeSciences worth $76K as of Q2 2026.
  • SignatureFD sold 2,126 Maravai LifeSciences shares in Q2 2026, an estimated $9.18K.
  • Maravai LifeSciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1612 holding.
  • SignatureFD first reported a position in Maravai LifeSciences in Q3 2021 and has held it in 20 quarters since.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.